Novo Nordisk offers Wegovy through its online pharmacy NovoCare.

Novo Nordisk is offering its weight loss drug Wegovy at half the original price through its new direct-to-consumer online pharmacy NovoCare, a cash payment program that costs $499 a month for millions of patients who don't have insurance coverage for the heavy-duty injection drug, which is priced near $1,350 a month. The move is aimed at expanding Wegovy's reach while ensuring patients use authentic drugs rather than cheaper generics that have become popular during the recent U.S. drug shortage. NovoCare will also provide patient support services such as home delivery, medication reminders and real-time support from company case managers.